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Adenocarcinoma is the most common metastatic
carcinoma in malignant serous effusions. A diag-
nosis of metastatic malignant serous effusion
raises the question of the origin of malignancy.
Clinical information, including previous history
of malignancy or obvious detectable tumor, is
cimportant in predicting the origin of metastati
adenocarcinoma in malignant body fluids.1–3
The correct diagnosis remains to be clarified even
when the morphology of the malignant cells is
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Background/Purpose: Pulmonary adenocarcinoma is a common malignancy of the pleural cavity. The
cell transfer technique can be used to create multiple slides from a single smear. The goal of this study was
to investigate the pulmonary origin of metastatic adenocarcinoma by evaluating the immunocytochemi-
ycal reactivity to thyroid transcription factor-1 (TTF-1) of slides of serous effusion specimens prepared b
the cell transfer technique.
Methods: In 2001, a total of 76 archived serous effusion specimens containing adenocarcinoma from  pa-
wtients were used in this study. The primary site of metastatic adenocarcinoma was determined by a revie
of the medical records. The cell transfer technique was used to create multiple slides from a single
Papanicolaou-stained smear. If more than 10% of the target cells reacted with perceptible intensity,
nuclear staining was considered to indicate a positive TTF-1 result.
Results: Positive rates of TTF-1 for body fluids collected from patients with lung, stomach, ovarian, breast,
colorectal and liver carcinomas were 41/50, 0/11, 0/6, 0/5, 0/2 and 0/1, respectively. Lung adenocarci-
noma showed TTF-1 positivity in 82% of specimens, and all other adenocarcinomas had negative TTF-1
staining results.
Conclusion: This study demonstrated that TTF-1 immunostaining in serous effusion specimens prepared
using the cell transfer technique is a sensitive and highly specific marker for metastatic lung adenocarci-
noma. [J Formos Med Assoc 2006;105(9):695–700]
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ORIGINAL ARTICLE
taken into account. The cytologic features of ade-
nocarcinomas often overlap with those of a vari-
ety of metastatic adenocarcinomas in the serous
cavity. This prompts a search for specific markers
to differentiate these metastatic serous fluids.
Thyroid transcription factor-1 (TTF-1) is a
novel homeodomain-containing protein that
participates in cell growth and differentiation
processes and is expressed selectively in the thy-
roid, diencephalon and the lungs.4 In the thyroid,
TTF-1 regulates the expression of thyroglobulin
and thyroperoxidase gene.5 In the lung, TTF-1 is ex-
pressed in type II pneumocytes and in nonciliated
bronchiolar epithelial (Clara) cells.6 TTF-1 plays a
critical functional role in the development of em-
bryonic epithelial cells. Expression of TTF-1 has
been documented in neoplasms arising from cells
that normally produce this transcription factor.7–11
Not only primary pulmonary carcinomas but also
metastatic lung carcinomas could demonstrate
TTF-1 immunoreactivity.12–28 However, previous
investigations have generally used immunohisto-
chemical study to examine the utility of TTF-1. A
few studies reported TTF-1 immunocytochemical
reactivity using cytologic specimens.17–22,26–28
The cell transfer technique allows the creation
of multiple slides for immunoassay from a single
smear preparation.28–30 This technique can trans-
fer an archived cytologic smear into several smaller
samples for immunostaining. This study exam-
ined the value of immunocytochemical reactivity
to TTF-1 as a marker of primary pulmonary origin
using smears obtained from serous effusion smear
archives prepared using the cell transfer technique.
Methods
Patients and specimens
In 2001, this retrospective study was performed
using the cytologic specimens of serous effusion
containing adenocarcinoma, including 74 pleural
fluid and two pericardial fluid specimens obtained
from the archives of the Cytology Laboratory 
of the Department of Laboratory Medicine of
National Taiwan University Hospital. The primary
site of metastatic adenocarcinoma was determined
by a review of the patient’s medical records in-
cluding clinical history, laboratory data, radio-
rlogic findings and histopathology. The cell transfe
technique was performed from the Papanicolaou-
stained smears to produce at least two slides from
each specimen for immunocytochemical staining.
Cell transfer technique
The Papanicolaou-stained slides, which were re-
screened, and monolayered areas with more ade-
nocarcinoma cells were dotted and then placed
rin xylene overnight to remove the cover slips. Afte
removing the cover slips, malinol (Muto Pure
Chemicals, Tokyo, Japan) was applied on the
smear drop by drop so that this liquid coverglass
medium covered the whole smear (Figure 1A).28–30
Then, the slides were put in an oven at 37° rC fo
r2–3 days until the medium hardened. All locato
flines and dots were transferred from the back o
the slide to the surface of the hardened medium.
The slides were immersed in warm water at 50°C
 for 1 hour. The malinol film was removed with
a sharp scalpel blade from the glass slide (Figure
1B). Once removed, the plastic film was sec-
tioned with scissors along the previously marked
lines (Figure 1C). A fragment was affixed onto a
triethoxyaminopropylsilane-coated glass slide in
water (Figure 1D). The slides were dried at room
temperature and then soaked in xylene to re-
move the cover glass medium. The slides were re-
ghydrated by immersing in a medium consistin
of absolute ethanol, 95% ethanol, 80%, 70%,
rand 50% ethanol, and then immersed into wate
serially. From each Papanicolaou-stained smear,
at least two slides were created using the cell
transfer technique for use in immunostaining.
Immunocytochemistry
For immunostaining, all transferred smears were
pretreated in a high pressure cooker (10 mM citrate
buffer, pH 6.0, 121°C for 15 minutes) for antigen
retrieval. Then, the smears were incubated with
TTF-1 antibody (dilution 1:200, clone 8G7G3/1;
DAKO, Carpinteria, CA, USA) at 4°C overnight.
The avidin–biotin–peroxidase method was used
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to visualize the antigen–antibody complexes with
3,3-diaminobenzidene as the chromogen.31 Posi-
tive control sections were stained in parallel and
included lung tissue containing lung adenocarci-
noma. Negative controls from each patient were
obtained by substituting phosphate-buffered saline
(PBS) for the primary antibody (TTF-1). The stain-
ing was considered positive if more than 10% 
of the neoplastic cells reacted with any inten-
sity.17,20,22,26,27 Only nuclear staining was consid-
ered acceptable for a positive TTF-1 result. Two
authors who were unaware of the primary site of
metastatic adenocarcinoma independently inter-
preted the staining results. When the findings were
interpreted differently, a consensus was reached on
the final judgment after detailed discussion.
Statistical analysis
The sensitivity and specificity of TTF-1 in body
fluid cytology for metastatic lung adenocarcinoma
were calculated using standard statistical methods
as previously described.32 The positive and nega-
tive predictive values of TTF-1 for adenocarci-
noma of lung origin were also calculated.
Results
The results of TTF-1 immunostaining are summa-
rized in the Table. Pulmonary adenocarcinoma
tissue controls showed appropriate nuclear stain-
ing in cancer cells for each batch of immuno-
staining. One of the transferred smears from each
patient served as negative control, which was re-
acted with PBS instead of TTF-1 antibody, show-
ing a negative result. One of the 76 transferred
smears did not show any cells after immunostain-
ing. This case was excluded from further analysis
because of the invalid immunostaining results. 
The diagnoses of the 75 patients with serous flu-
ids containing metastatic adenocarcinoma inclu-
ded lung cancer in 50, stomach cancer in 11,
f fImmunocytochemistry via cell trans er in body luid
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iF gure 1. ll f h ( ) h d h l d d k d f l fCe  trans er tec nique. A  T e smear is covere  wit  transparent cover g ass me ium an  mar e  or i ting
after hardening. (B) The medium film is removed with a sharp scalpel blade from the glass slide. (C) Lifted smear prepa-
ration remains to be cut for another staining. (D) Cell-transferred smear prepared from the above lifted smear.
ovarian cancer in six, breast cancer in five, colorectal
cancer in two and hepatocellular carcinoma in one.
Lung adenocarcinoma showed TTF-1 positivity in
82% (41/50) of patients. Anti-TTF-1 disclosed a
distinct nuclear-staining pattern in positive cases
(Figure 2). The staining pattern of negative control
is also shown in Figure 2. All other adenocarcino-
mas metastasizing from the stomach, ovary, breast,
colorectum and liver showed negative TTF-1 stain-
ing. Mesothelial cells detected in the background
did not show TTF-1 activity in any case. Rare arti-
facts included nonspecific cytoplasmic membrane
staining seen in tightly cohesive cancer cell balls.
Overall, the sensitivity and specificity of TTF-1 in
body fluid cytology for metastatic lung adenocarci-
noma were 82% and 100%, respectively. Although
the negative predictive value was 74% (25/34), the
positive predictive value reached 100%.
Discussion
The cell transfer technique is useful not only in
the restoration of broken cytology slides but also
in the creation of multiple slides from a single
smear preparation.29 In this study, each fluid spec-
imen for routine examination was prepared into
 two smears, one with Papanicolaou stain and
the other with Riu stain. In order to perform
immunocytochemical study with TTF-1 and to
make a negative control smear, multiple slides were
rprepared from the Papanicolaou-stained smea
using the cell transfer technique. One of the cell-
transferred smears was found to have lost the
transferred cells after immunostaining. Although
we used coated glass slides, scant cellularity on
fthe transferred smears and the detachment o
ycells from the coated slide during staining ma
have resulted in the failure of immunostaining.
rTTF-1 has been reported to be a useful marke
cfor lung cancer in both cytologic and histologi
specimens.7–28 In this study, 82% of lung ade-
nocarcinomas expressed TTF-1 and none of the
nonpulmonary adenocarcinomas showed TTF-1
reactivity. The positivity of TTF-1 could reach 100%
in paraffin sections of histologic specimens.12 In
the sections of cell blocks of adenocarcinoma in
body fluids, the reported sensitivity of TTF-1 was
between 54% and 88.2%.17–20 In 2004, Liu and
Farhood26 compared the TTF-1 expression in cell-
ktransferred direct smears with those of cell bloc
preparations. Out of 14 (85.7%) fine-needle
aspiration specimens of pulmonary adenocarci-
noma, 12 showed TTF-1 positivity on both trans-
ferred smears and cell block sections.26 Gong et al28
validated the immunostains on cell-transferred
cytologic specimens using 22 cytologic speci-
mens and 21 commonly rused antibodies. In thei
study, 100 transferred smears were immuno-
stained, of which five (5%) were lost during the
staining procedure. In the present study, we ana-
ylyzed 76 cell-transferred body fluid smears, onl
one of which was lost (1.3%) and 82% of metasta-
tic lung adenocarcinomas expressed TTF-1.
gIn summary, immunocytochemical stainin
ris often limited by the unavailability of smears o
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Table. Results of thyroid transcription factor-1
(TTF-1) immunostaining in adenocarcinomas
from serous fluid specimens
Primary No. of TTF-1 reactivity
site cases n (%)
Lung 50 41 (82) 
Stomach 11 0 (0)
Ovary 6 0 (0)
Breast 5 0 (0)
Colorectum 2 0 (0)
Liver 1 0 (0)
Total 75
iF gure 2. Thyroid transcription factor-1 immunostaining
in cell-transferred smear from metastatic pulmonary ade-
nocarcinoma showing positive staining. Inset: negative
control (400×).
by lack of cell blocks containing carcinoma cells.
The cell transfer technique can create multiple
smears from a single smear for use in immuno-
staining. This study also confirmed that TTF-1 is
a sensitive, highly specific marker for metastatic
lung adenocarcinoma in serous effusion speci-
mens prepared with this technique.
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